Pharmaceuticals in France
Summary
Pharmaceuticals in France industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2019-24, and forecast to 2029). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
Pharmaceuticals in France industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2019-24, and forecast to 2029). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The pharmaceutical market includes sales of both prescriptions and over-the-counter (OTC) drugs. The market scope does not cover consumer healthcare and animal health products.
- The French pharmaceuticals market recorded revenues of $48.6 billion in 2024, representing a compound annual growth rate (CAGR) of 4.5% between 2019 and 2024.
- The oncology drugs segment accounted for the market's largest proportion in 2024, with total revenues of $5.5 billion, equivalent to 11.2% of the market's overall value.
- The French pharmaceuticals market witnessed healthy growth in 2024, registering an annual growth of 6.3%.
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in France
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in France
- Leading company profiles reveal details of key pharmaceuticals market players? global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the France pharmaceuticals market with five year forecasts by both value and volume
- What was the size of the France pharmaceuticals market by value in 2024?
- What will be the size of the France pharmaceuticals market in 2029?
- What factors are affecting the strength of competition in the France pharmaceuticals market?
- How has the market performed over the last five years?
- What are the main segments that make up France's pharmaceuticals market?
1 EXECUTIVE SUMMARY
1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
4 MARKET SEGMENTATION
4.1. Category segmentation
4.2. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Who are the leading players?
7.2. What are the strengths of the leading players?
7.3. What are the recent developments in the market?
8 COMPANY PROFILES
8.1. Sanofi
8.2. Laboratoires Pierre Fabre SA
8.3. Les Laboratoires Servier SAS
8.4. Ipsen SA
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
4 MARKET SEGMENTATION
4.1. Category segmentation
4.2. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Who are the leading players?
7.2. What are the strengths of the leading players?
7.3. What are the recent developments in the market?
8 COMPANY PROFILES
8.1. Sanofi
8.2. Laboratoires Pierre Fabre SA
8.3. Les Laboratoires Servier SAS
8.4. Ipsen SA
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
LIST OF TABLES
Table 1: France pharmaceuticals market value: $ million, 2019-24
Table 2: France pharmaceuticals market category segmentation: % share, by value, 2019-24
Table 3: France pharmaceuticals market category segmentation: $ million, 2019-24
Table 4: France pharmaceuticals market geography segmentation: $ million, 2024
Table 5: France pharmaceuticals market value forecast: $ million, 2024-29
Table 6: Sanofi: Key Facts
Table 7: Sanofi: Annual Financial Ratios
Table 8: Sanofi: Key Employees
Table 9: Sanofi: Key Employees Continued
Table 10: Laboratoires Pierre Fabre SA: Key Facts
Table 11: Laboratoires Pierre Fabre SA: Key Employees
Table 12: Les Laboratoires Servier SAS: Key Facts
Table 13: Les Laboratoires Servier SAS: Key Employees
Table 14: Ipsen SA: Key Facts
Table 15: Ipsen SA: Annual Financial Ratios
Table 16: Ipsen SA: Key Employees
Table 17: France Size of Population (Million), 2020-24
Table 18: France Real GDP (Constant 2010 Prices, $ Billion), 2020-24
Table 19: France GDP (Current Prices, $ Billion), 2020-24
Table 20: France Inflation, 2020-24
Table 21: France Consumer Price Index (Absolute), 2020-24
Table 22: France Exchange Rate, 2019-24
Table 1: France pharmaceuticals market value: $ million, 2019-24
Table 2: France pharmaceuticals market category segmentation: % share, by value, 2019-24
Table 3: France pharmaceuticals market category segmentation: $ million, 2019-24
Table 4: France pharmaceuticals market geography segmentation: $ million, 2024
Table 5: France pharmaceuticals market value forecast: $ million, 2024-29
Table 6: Sanofi: Key Facts
Table 7: Sanofi: Annual Financial Ratios
Table 8: Sanofi: Key Employees
Table 9: Sanofi: Key Employees Continued
Table 10: Laboratoires Pierre Fabre SA: Key Facts
Table 11: Laboratoires Pierre Fabre SA: Key Employees
Table 12: Les Laboratoires Servier SAS: Key Facts
Table 13: Les Laboratoires Servier SAS: Key Employees
Table 14: Ipsen SA: Key Facts
Table 15: Ipsen SA: Annual Financial Ratios
Table 16: Ipsen SA: Key Employees
Table 17: France Size of Population (Million), 2020-24
Table 18: France Real GDP (Constant 2010 Prices, $ Billion), 2020-24
Table 19: France GDP (Current Prices, $ Billion), 2020-24
Table 20: France Inflation, 2020-24
Table 21: France Consumer Price Index (Absolute), 2020-24
Table 22: France Exchange Rate, 2019-24
LIST OF FIGURES
Figure 1: France pharmaceuticals market value: $ million, 2019-24
Figure 2: France pharmaceuticals market category segmentation: $ million, 2019-24
Figure 3: France pharmaceuticals market geography segmentation: % share, by value, 2024
Figure 4: France pharmaceuticals market value forecast: $ million, 2024-29
Figure 5: Forces driving competition in the pharmaceuticals market in France, 2024
Figure 6: Drivers of buyer power in the pharmaceuticals market in France, 2024
Figure 7: Drivers of supplier power in the pharmaceuticals market in France, 2024
Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in France, 2024
Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in France, 2024
Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in France, 2024
Figure 1: France pharmaceuticals market value: $ million, 2019-24
Figure 2: France pharmaceuticals market category segmentation: $ million, 2019-24
Figure 3: France pharmaceuticals market geography segmentation: % share, by value, 2024
Figure 4: France pharmaceuticals market value forecast: $ million, 2024-29
Figure 5: Forces driving competition in the pharmaceuticals market in France, 2024
Figure 6: Drivers of buyer power in the pharmaceuticals market in France, 2024
Figure 7: Drivers of supplier power in the pharmaceuticals market in France, 2024
Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in France, 2024
Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in France, 2024
Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in France, 2024
